Status:
COMPLETED
Low and High Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis
Lead Sponsor:
Ahi Evran University Education and Research Hospital
Conditions:
Lateral Epicondylitis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Lateral epicondylitis (tennis elbow) is an enthesopathy seen in 1-2% of the population aged 30-65 years, which can occur in the lateral epicondyle origo of the extensor carpi radialis brevis and longu...
Detailed Description
Lateral epicondylitis (tennis elbow) is an enthesopathy seen in 1-2% of the population aged 30-65 years, which can occur in the lateral epicondyle origo of the extensor carpi radialis brevis and longu...
Eligibility Criteria
Inclusion
- Those who admit Kirsehir Ahi Evran University Hospital and is diagnosed with lateral epicondylitis,
- Participants with unilateral or bilateral lateral epicondylitis and pain and functional limitations due to this condition,
- who can read and write in Turkish,
- participant's admission participating in the study,
- participants who do not have exclusion criteria,
Exclusion
- receiving any injection therapy to the elbow area in the last 3 months,
- participants with complaints less than 3 months(acute lateral epicondylitis)
- previously surgery on the elbow area,
- having a history of acute trauma or fracture in the elbow area,
- have local dermatological problems,
- have a local infection in the treatment area,
- those who are allergic to dextrose,
- with coagulation disorders or using anticoagulant drugs,
- with an autoimmune disease,
- with type 1 or type 2 diabetes mellitus,
- have unregulated hypertension,
- have immune dysfunction,
- with malignancy or diagnosed with a malignancy in the last 5 years,
- pregnancy or lactation,
- having cervical radiculopathy in the same extremity,
- with cognitive dysfunction,
- patients with paralysis in the same extremity,
- lack of cooperation due to cognitive impairment,
- participant's refusal to participate in the study.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 21 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04680936
Start Date
January 1 2021
End Date
May 21 2022
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kirsehir Ahi Evran University Hospital
Kırşehir, Turkey (Türkiye)